Pure Global AI
ANVISA registration 10345162547Active

HUMAN BRAIN NATRIURETIC PEPTIDE (BNP)

ANVISA Registration Number: 10345162547SIEMENS HEALTHCARE DIAGNÓSTICOS LTDASIEMENS HEALTHCARE DIAGNOSTICS INC.Risk Class III
Verified
Device names
Technical name
HUMAN BRAIN NATRIURETIC PEPTIDE (BNP)
View exact technical-name matches →
PT: PEPTÍDEO NATRIURÉTICO CEREBRAL HUMANO (BNP)
Commercial name
ADVIA Centaur NT-proBNPII (PBNPII)
View exact commercial-name matches →
Risk class
Class III
Registration details
Registration Number
10345162547
Process Number
25351059326202551
CNPJ
01449930000190
Company information
Registration Holder
SIEMENS HEALTHCARE DIAGNÓSTICOS LTDA
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS INC.
Manufacturing Country
United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
Publication Date
Sep 15, 2025
Status
Active
About this record

Access comprehensive regulatory information for HUMAN BRAIN NATRIURETIC PEPTIDE (BNP) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10345162547 and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS INC.. The registration is held by SIEMENS HEALTHCARE DIAGNÓSTICOS LTDA with validity until Sep 15, 2035.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.